Stroke DX
Explore this company’s associated devices, FDA decisions and regulatory history.

Stroke DX
- Regulatory records
- 1
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 1 FDA record to the applicant name Stroke DX. The collection includes 1 510(k) clearance. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Jul 22, 2026 to Jul 22, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code QAF appears in 1 of the 1 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 300 Corporate Pt.E, Suite 310, Culver City, CA, 90230, US. Recorded on K253840, decision dated Jul 22, 2026.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Devices & associated records
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
STEDI Scan DeviceK253840 | Stroke DX | 510(k) clearance | Jul 22, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.
